125 related articles for article (PubMed ID: 6331655)
21. Specific 1,25-hydroxycholecalciferol receptors and stimulation of 25-hydroxycholecalciferol-24R hydroxylase in human amniotic cells.
Delvin EE; Pilon AM; Vekemans M
Pediatr Res; 1987 May; 21(5):432-5. PubMed ID: 3035472
[TBL] [Abstract][Full Text] [Related]
22. Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice.
Merke J; Schwittay D; Fürstenberger G; Gross M; Marks F; Ritz E
Calcif Tissue Int; 1985 May; 37(3):257-67. PubMed ID: 2990643
[TBL] [Abstract][Full Text] [Related]
23. Presence of 1,25-dihydroxy vitamin D receptor in normal and abnormal breast tissue.
Eisman JA; Martin TJ; MacIntyre I
Prog Biochem Pharmacol; 1980; 17():143-50. PubMed ID: 6259652
[TBL] [Abstract][Full Text] [Related]
24. Specific cytosol binding proteins for 25(OH)D3 and 1.25(OH)2D3 in human breast cancers.
Nakata M; Tsuboi S; Takenaka M; Konishi Y; Kawashima R; Tomita M; Nakagawa T; Iwamura N; Fujita T
Endocrinol Jpn; 1981 Dec; 28(6):741-6. PubMed ID: 6286292
[TBL] [Abstract][Full Text] [Related]
25. Self-induction of 1,25-dihydroxyvitamin D3 metabolism limits receptor occupancy and target tissue responsiveness.
Reinhardt TA; Horst RL
J Biol Chem; 1989 Sep; 264(27):15917-21. PubMed ID: 2550427
[TBL] [Abstract][Full Text] [Related]
26. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
27. Association of 1,25-dihydroxyvitamin D3 with cultured 3T6 mouse fibroblasts. Cellular uptake and receptor-mediated migration to the nucleus.
Pike JW; Haussler MR
J Biol Chem; 1983 Jul; 258(14):8554-60. PubMed ID: 6305993
[TBL] [Abstract][Full Text] [Related]
28. Demonstration and characterization of a 1 alpha,25-(OH)2D3 receptor-like macromolecule in cultured rat pituitary cells.
Haug E; Gautvik KM
J Steroid Biochem; 1985 Nov; 23(5A):625-35. PubMed ID: 3001410
[TBL] [Abstract][Full Text] [Related]
29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
30. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moore GE; Moseley JM; Martin TJ
Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
[TBL] [Abstract][Full Text] [Related]
31. I alpha, 25-Dihydroxyvitamin D3 receptor in the X-linked hypophosphatemic mouse.
Seino Y; Sierra RI; Ichikawa M; Avioli LV
Endocrinology; 1982 Jul; 111(1):329-31. PubMed ID: 6282570
[TBL] [Abstract][Full Text] [Related]
32. Effect of 1,25-dihydroxyvitamin D3 on mouse mammary tumor (GR) cells: evidence for receptors, cellular uptake, inhibition of growth and alteration in morphology at physiologic concentrations of hormone.
Gross M; Kost SB; Ennis B; Stumpf W; Kumar R
J Bone Miner Res; 1986 Oct; 1(5):457-67. PubMed ID: 2845731
[TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
34. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
35. Evidence for in vivo upregulation of 1,25(OH)2 vitamin D3 receptor in human monocytes.
Merke J; Nawrot M; Hügel U; Szabo A; Ritz E
Calcif Tissue Int; 1989 Oct; 45(4):255-6. PubMed ID: 2553225
[TBL] [Abstract][Full Text] [Related]
36. Studies of the effect of 1,25-dihydroxycholecalciferol on the proliferation and differentiation of the human promyelocytic leukaemia cell line HL-60.
Djulbegović B; Christmas SE; Evans G; Moore M
Biomed Pharmacother; 1986; 40(10):407-16. PubMed ID: 3472610
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells. Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake.
Lamberg-Allardt C; Valtonen E; Polojärvi M; Stewen P
Mol Cell Endocrinol; 1991 Oct; 81(1-3):25-31. PubMed ID: 1665829
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D and the hematolymphopoietic tissue: a 1994 update.
Manolagas SC; Yu XP; Girasole G; Bellido T
Semin Nephrol; 1994 Mar; 14(2):129-43. PubMed ID: 8177980
[TBL] [Abstract][Full Text] [Related]
39. 1,25-Dihydroxyvitamin D3 binds specifically to rat vascular smooth muscle cells and stimulates their proliferation in vitro.
Koh E; Morimoto S; Fukuo K; Itoh K; Hironaka T; Shiraishi T; Onishi T; Kumahara Y
Life Sci; 1988; 42(2):215-23. PubMed ID: 2826956
[TBL] [Abstract][Full Text] [Related]
40. Stabilization of labile glucocorticoid-receptor complexes from acute nonlymphocytic leukemia cells by a factor from chronic lymphocytic leukemia cells.
Holbrook NJ; Bloomfield CD; Munck A
Cancer Res; 1984 Jan; 44(1):407-14. PubMed ID: 6690056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
